Patent Assignment
Reel/Frame 015962/0734
Change of Name
Recorded: 2005-03-29
Received: 2005-03-29
Pages: 9
Assignor
EPIX MEDICAL, INC.
Executed: 2004-09-07
Assignee
EPIX PHARMACEUTICALS, INC.
161 FIRST STREET, CAMBRIDGE, MA, 02142, UNITED STATES
Covered Properties
(30)
Detection and treatment of intravascular lesions
Application:
10/492,108 →
Steady state perfusion methods
Application:
60/649,713 →
Contrast-Enhanced Diagnostic Imaging Method for Monitoring Interventional Therapies
Application:
10/961,872 →
Polypeptide Conjugates with Extended Circulating Half-Lives
Application:
10/487,025 →
Methods of cardiothoracic imaging - (MET-30)
Application:
10/888,833 →
Optically pure and enriched isomers of chelating ligands and contrast agents
Application:
10/850,134 →
Peptide-Based Multimeric Targeted Contrast Agents
Application:
10/786,791 →
Stationary target imaging
Application:
60/543,875 →
Bioactivated Diagnostic Imaging Constrast Agents
Application:
10/758,729 →
Diagnostic Imaging Contrast Agents with Extended Blood Retention
Application:
10/755,507 →
Diagnostic Imaging Contrast Agents with Extended Blood Retention
Application:
10/755,506 →
Peptide Aggregates
Application:
10/635,838 →
Stationary target imaging
Application:
60/486,833 →
Targeting multimeric imaging agents through multilocus binding
Application:
10/445,544 →
Optically pure and enriched isomers of chelating ligands and contrast agents
Application:
60/473,369 →
Magnetic Resonance Angiography Data
Application:
10/365,350 →
Diagnostic Imaging Contrast Agents with Extended Blood Retention
Application:
10/354,723 →
Imaging Sexual Response
Application:
10/291,900 →
Peptide aggregates
Application:
60/401,617 →
Peptide-Based Multimeric Targeted Contrast Agents
Application:
10/209,172 →
Peptide-based multimeric targeted contrast agents
Application:
10/209,183 →
Systems and Methods for Targeted Magnetic Resonance Imaging of the Vascular System
Application:
10/209,416 →
Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage
Application:
10/200,477 →
Diagnostic Imaging Contrast Agents with Extended Blood Retention
Application:
10/034,522 →
Detection and treatment of intravascular lesions
Application:
60/330,156 →
Bioactivated Diagnostic Imaging Contrast Agents
Application:
09/952,971 →
Protein conjugates with extended circulating half-lives
Application:
60/311,557 →
Peptide-based multimeric targeted contrast agents
Application:
60/308,721 →
Systems and methods for targeted magnetic resonance imaging of the vasculature
Application:
60/308,690 →
Magnetic Resonance Angiography Data
Application:
09/778,585 →